Premium
CorMedix Inc (CRMD)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-01-23 | Ms. Kaufman Beth ZelnickEVP, Chief Legal and Compliance Officer & Corporate Secretary | -8,80k | 64,00k | Sale to Issuer | 7,27 | - | - |
| 2026-01-23 | Ms. Susan BlumEVP & CFO | -9,77k | 71,01k | Sale to Issuer | 7,27 | 8,44k | -53,65% |
| 2026-01-23 | Ms. Elizabeth Masson-HurlburtExec. VP, COO & Chief Integration Officer | -10,78k | 78,36k | Sale to Issuer | 7,27 | 76,76k | -12,31% |
| 2026-01-23 | Mr. Joseph TodiscoCEO & Chairman of the Board of Directors | -27,31k | 198,51k | Sale to Issuer | 7,27 | 344,61k | -7,34% |
| 2026-01-21 | Ms. Janet M. DillioneIndependent Director | -10,00k | 68,80k | Vente | 6,88 | 38,47k | -20,63% |
| 2026-01-12 | Ms. Elizabeth Masson-HurlburtExec. VP, COO & Chief Integration Officer | -5,79k | 41,43k | Sale to Issuer | 7,15 | 51,79k | -10,06% |
| 2026-01-16 | Mr. Joseph TodiscoCEO & Chairman of the Board of Directors | 6,92k | 23,39k | Derivative Exercise and Retained Stock | 3,38 | 371,92k | 1,90% |
| 2026-01-16 | Mr. Joseph TodiscoCEO & Chairman of the Board of Directors | -22,67k | 77,06k | Derivative Exercise and Sale | 3,38 - 6,78 | 371,92k | - |
| 2026-01-12 | Mr. Joseph TodiscoCEO & Chairman of the Board of Directors | -17,42k | 124,53k | Sale to Issuer | 7,15 | 371,92k | -4,47% |
| 2026-01-12 | Mr. Steven W. LefkowitzIndependent Director | 15,00k | 84,45k | Derivative Exercise and Retained Stock | 5,63 | 72,50k | 26,09% |
| 2026-01-02 | Ms. Elizabeth Masson-HurlburtExec. VP, COO & Chief Integration Officer | -10,90k | 132,48k | Sale to Issuer | 12,16 | 45,08k | -19,46% |
| 2026-01-02 | Ms. Kaufman Beth ZelnickEVP, Chief Legal and Compliance Officer & Corporate Secretary | -11,33k | 137,81k | Sale to Issuer | 12,16 | - | - |
| 2025-12-30 | Dr. Alan W. DuntonIndependent Director | -20,00k | 179,40k | Derivative Exercise and Sale | 4,03 - 13,00 | 15,25k | - |
| 2025-12-18 | Mr. Joseph TodiscoCEO & Chairman of the Board of Directors | -30,00k | 227,10k | Derivative Exercise and Sale | 4,43 - 12,00 | 302,21k | - |
| 2025-12-09 | Ms. Janet M. DillioneIndependent Director | -34,00k | 142,10k | Derivative Exercise and Sale | 5,63 - 12,00 | 23,47k | - |
| 2025-12-09 | Mr. Steven W. LefkowitzIndependent Director | -40,00k | 475,20k | Vente | 11,88 | 57,50k | -41,03% |
| 2025-12-02 | Ms. Janet M. DillioneIndependent Director | -46,66k | 281,77k | Derivative Exercise and Sale | 3,55 - 10,00 | 23,47k | - |
| 2025-11-24 | Ms. Janet M. DillioneIndependent Director | -26,34k | 165,64k | Derivative Exercise and Sale | 2,85 - 9,93 | 23,47k | - |
| 2025-11-14 | Ms. Janet M. DillioneIndependent Director | -30,00k | 342,60k | Vente | 11,42 | 23,47k | -56,10% |
| 2025-10-23 | Mr. Myron KaplanLead Independent Director | 25,00k | 275,50k | Achat | 11,02 | 206,03k | 13,81% |
| 2025-09-16 | Mr. Gregory DuncanIndependent Director | 13,33k | 110,93k | Derivative Exercise and Retained Stock | 8,32 | 38,33k | 53,33% |
| 2025-09-12 | Dr. Alan W. DuntonIndependent Director | -10,00k | 95,80k | Derivative Exercise and Sale | 3,55 - 13,13 | 15,25k | - |
| 2025-09-12 | Mr. Joseph TodiscoCEO & Chairman of the Board of Directors | -50,00k | 476,50k | Derivative Exercise and Sale | 3,47 - 13,00 | 302,21k | - |
| 2025-05-10 | Mr. Joseph TodiscoCEO & Chairman of the Board of Directors | -21,23k | 247,48k | Sale to Issuer | 11,66 | 302,21k | -6,56% |
| 2025-09-09 | Ms. Kaufman Beth ZelnickEVP, Chief Legal and Compliance Officer & Corporate Secretary | -50,00k | 505,26k | Derivative Exercise and Sale | 3,30 - 13,41 | - | - |
| 2025-09-09 | Ms. Elizabeth Masson-HurlburtExec. VP, COO & Chief Integration Officer | -54,00k | 633,52k | Derivative Exercise and Sale | 1,45 - 13,51 | 34,10k | - |
| 2025-08-29 | Ms. Elizabeth Masson-HurlburtExec. VP, COO & Chief Integration Officer | -8,42k | 124,93k | Sale to Issuer | 14,83 | 34,10k | -19,81% |
| 2025-08-29 | Ms. Kaufman Beth ZelnickEVP, Chief Legal and Compliance Officer & Corporate Secretary | -8,88k | 131,69k | Sale to Issuer | 14,83 | - | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
